Jessica D McDermott
Overview
Explore the profile of Jessica D McDermott including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
631
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Stokes W, Eguchi M, Amini A, Hararah M, Ding D, McDermott J, et al.
Oral Oncol
. 2018 Aug;
84:12-19.
PMID: 30115470
Objectives: Recent preclinical research has renewed interest in the interplay between glucose dysregulation and cancer. Metformin holds promise as an adjunctive antineoplastic agent in head and neck cancer (HNC). We...
12.
Stokes W, Sumner W, Breggren K, Rathbun J, Raben D, McDermott J, et al.
Rep Pract Oncol Radiother
. 2017 Aug;
22(5):389-395.
PMID: 28808428
Aim: To present our experience comparing cisplatin- and cetuximab-based radiotherapy for locally-advanced head and neck squamous cell carcinoma. Background: The comparative effectiveness of cisplatin-based chemoradiotherapy (CRT) versus cetuximab-based bioradiotherapy (BRT)...
13.
Sumner W, Stokes W, Oweida A, Berggren K, McDermott J, Raben D, et al.
J Transl Med
. 2017 Aug;
15(1):168.
PMID: 28764811
Background: Squamous cell carcinoma of the head and neck (HNSCC) represents an array of disease processes with a generally unfavorable prognosis. Inflammation plays an important role in tumor development and...
14.
Rusthoven C, Lanning R, Jones B, Amini A, Koshy M, Sher D, et al.
Radiother Oncol
. 2017 Apr;
124(1):139-146.
PMID: 28433411
Background And Purpose: Radiotherapy (RT) to the primary nasopharyngeal tumor is frequently offered to patients with metastatic nasopharyngeal carcinoma (mNPC). However, only limited data exist to support RT in this...
15.
Robin T, Jones B, Gordon O, Phan A, Abbott D, McDermott J, et al.
Cancer
. 2017 Apr;
123(16):3040-3049.
PMID: 28369832
Background: Sinonasal malignancies are a rare and heterogeneous group of tumors for which there is a paucity of robust data with which to guide management decisions. The authors used the...
16.
Stokes W, Amini A, Jones B, McDermott J, Raben D, Ghosh D, et al.
Head Neck
. 2017 Mar;
39(6):1113-1121.
PMID: 28301079
Background: Adding induction chemotherapy to concurrent chemotherapy and radiotherapy (RT) has generally not improved the overall survival (OS) in randomized trials of patients with head and neck cancer. This failure...
17.
Stokes W, Jones B, Bhatia S, Oweida A, Bowles D, Raben D, et al.
Cancer
. 2016 Oct;
123(4):600-608.
PMID: 27727461
Background: Although laryngectomy is the treatment of choice for patients with T4 larynx cancer, many patients are unable or unwilling to undergo laryngectomy and instead pursue larynx-preservation strategies combining radiotherapy...
18.
Amini A, Waxweiler T, Brower J, Jones B, McDermott J, Raben D, et al.
JAMA Otolaryngol Head Neck Surg
. 2016 Aug;
142(11):1100-1110.
PMID: 27541166
Importance: Data on adjuvant concurrent chemoradiotherapy (CRT) after resection of salivary gland carcinomas (SGCs) are limited. Objective: To examine overall survival (OS) outcomes of patients who receive CRT vs radiotherapy...
19.
Wang K, Russell J, McDermott J, Elvin J, Khaira D, Johnson A, et al.
Clin Cancer Res
. 2016 Jun;
22(24):6061-6068.
PMID: 27334835
Purpose: We sought to identify genomic alterations (GA) in salivary gland adenocarcinomas, not otherwise specified (NOS), salivary duct carcinomas (SDC), carcinoma ex pleomorphic adenoma (ca ex PA), and salivary carcinoma,...
20.
Amini A, Jasem J, Jones B, Robin T, McDermott J, Bhatia S, et al.
Oral Oncol
. 2016 Apr;
56:1-7.
PMID: 27086480
Objectives: This study identifies clinical characteristics associated with HPV-positive oropharynx squamous cell carcinoma (OPSCC) and evaluates predictors of overall survival (OS) in HPV-positive patients undergoing definitive treatment within the National...